Astrazeneca's olaparib drug voted against by FDA advisory committee - UPDATE
26th Jun 2014 07:08
It was disappointing news for AstraZeneca after an advisory committee to the US Food and Drug Administration (FDA) voted 11 to two that there was not enough evidence to support an accelerated approval for the use of olaparib as a maintenance treatment for women with a specific type of ovarian cancer
Read moreSunday newspaper round-up: Tesco, AstraZeneca, Asos
22nd Jun 2014 13:02
Some of Tesco's biggest shareholders have complained to the retailer's senior independent director (Sid) about its strategy and management, the Sunday Times said. An unidentified top 10 shareholder said it expressed its concerns with the Sid, Patrick Cescau, and not Tesco's Chairman, Sir Richard Bro
Read moreSector movers: Shire soars as M&A fever boosts pharma, health stocks
20th Jun 2014 13:56
News that Shire has rejected a £27bn approach by AbbVie sent shares in the pharmaceutical and healthcare equipment sectors higher on Friday as yet more M&A continued to give sentiment a boost. "A bit of M&A excitement has been just the ticket to enliven trading on what may otherwise have been somet
Read moreLondon midday: Stocks rise as M&A boosts Shire, TSB jumps on debut
20th Jun 2014 11:39
- FTSE 100 at one-week high - Shire jumps after rejecting £27bn AbbVie proposal - TSB rises strongly after IPO - Iran still in the spotlight as Obama sends advisers techMARK 2,849.46 +1.26% FTSE 100 6,827.82 +0.29% FTSE 250 15,761.52 +0.49% UK stocks were making gains on Friday as yet more M&A fev
Read moreLondon midday: Stocks erase gains on Iraq concerns, mixed UK data
17th Jun 2014 11:20
- M&A and deals lift a number of blue chips - UK inflation drops to four-and-a-half year low - UK house prices surge 9.9% - Iraq concerns still weighing on risk appetite techMARK 2,794.67 -0.09% FTSE 100 6,755.68 +0.02% FTSE 250 15,660.55 -0.29% London stocks fluctuated at a seven-week low on Tues
Read moreLondon open: Stocks rebound from seven-week low, but Iraq still in focus
17th Jun 2014 08:20
- FTSE 100 rebounds from lowest since April 28th - Iraq tensions continue, US deploys troops - UK inflation data in focus - Shire gains on M&A hopes, Astra also in spotlight techMARK 2,802.94 +0.21% FTSE 100 6,762.27 +0.11% FTSE 250 15,730.40 +0.15% UK stocks rose slightly on Tuesday morning, boun
Read moreAstraZeneca looking at ways of boosting shareholder value
17th Jun 2014 08:14
Drugs giant AstraZeneca is on the lookout for new potential acquisitions and partnerships in an effort to improve shareholder value, according to reports. Following the company's rejection of Pfizer's bid last month, Chief Executive Pascal Soriot is said to have sought advice from investment bank C
Read moreSunday share tips: Whitbread, Petra Diamonds, Empiric Student Property
15th Jun 2014 12:28
Whitbread looks like a reliable investment despite the imminent departure of Chairman Anthony Habgood, Matthew Goodman said in the Sunday Times's Inside the City column. The company was a mess when Habgood took over in 2005 but he has sold peripheral businesses to focus on Premier Inn and Costa Coff
Read moreFTSE 100 movers: Oil stocks gain as housing stocks dive
13th Jun 2014 15:39
Oil and gas stocks were among the handful of names making gains today as share prices tracked oil prices higher, with Shell, BG Group and BP on the rise. Oil prices have surged to a nine-month high amid growing fears about the situation in Iraq, a major oil producer. United Utilities was one of t
Read moreAstraZeneca cheered by FDA's decision to avoid cardiovascular trial
13th Jun 2014 07:06
AstraZeneca has welcomed a vote by a committee of the US Food and Drug Administration (FDA) against the necessity of a trial looking specifically into cardiovascular outcomes of its Movantik drug, which has been developed to treat constipation associated with opioid pain medications. The meeting o
Read moreLondon midday: Stocks erase losses as media strength outweighs miners
12th Jun 2014 11:27
- Media stocks lead the rebound, ITV jumps - Mining stocks fall, Anglo downgraded - Eurozone industrial data beats forecasts - Iraq tensions keep risk appetite subdued techMARK 2,845.86 +0.18% FTSE 100 6,841.76 +0.04% FTSE 250 16,111.37 +0.15% A late-morning bounce pushed UK stocks into positive t
Read moreLondon open: Mining stocks pull FTSE 100 lower ahead of data
12th Jun 2014 08:25
- Profit taking continues as miners fall - Traders await global economic data - Broker downgrades hit blue chips techMARK 2,839.63 -0.04% FTSE 100 6,827.09 -0.17% FTSE 250 16,073.58 -0.09% UK stocks opened flat on Thursday morning as weakness in the mining sector held back any chances of a rebound
Read moreAstraZeneca signs licence deal with Synairgen
12th Jun 2014 07:42
British drugs maker AstraZeneca has signed a licence agreement with AIM-listed Synairgen for the development of SNG000l, a treatment for respiratory tract viral infections in patients with severe asthma. Under the deal, FTSE 100-listed Astra will pay Synairgen a $7.25m up-front fee and potential de
Read moreAstrazeneca to present 43 abstracts at US diabetes conference
11th Jun 2014 07:47
Drug giant AstraZeneca on Wednesday revealed that the American Diabetes Association (ADA) in San Francisco has accepted 43 diabetes research and development studies. The FTSE 100 group, which has been facing a takeover bid from US rival Pfizer, will present clinical data from a number of analyses,
Read moreAstraZeneca looking to fast-track lung cancer drugs
3rd Jun 2014 07:51
Biopharmaceutical giant AstraZeneca is reportedly planning to make available to UK patients two of its main lung cancer drugs long before they have undergone full clinical testing under the recently launched scheme that fast-tracks the most promising new drug developments. The programme, which was
Read more